CuRE Crucible

What sets it apart

• Authors the actual pipeline — assets, programs, and named base/bull/bear assumption sets — and captures the go/no-go as an attributed, hash-chained decision-of-record, with a probabilistic eNPV fan chart from Calculate.
• RWD-conditioned probability-of-success is the wedge no portfolio-economics incumbent (Cytel / Berry / Certara) can match — PoS priors are conditioned on the platform's own real-world data via Calculate + Conduct, not analyst guesswork.
• A distinct decision layer on the shared Calculate engine (the Caliber-from-Calculate shape, ADR-PLT-008): Crucible owns the program-economics domain, the go/no-go workflow, and the portfolio buyer surface; Calculate owns the versioned eNPV / VoI / PoS methodology it consumes — never re-implemented.
• Board-level program economics live under an elevated R&D-strategy / corp-dev persona, org-private by default — a distinct governance surface from the clinical consent / DUA stack, not a reuse of it.
• The decision-of-record is attributed, hash-chained, and append-only — go/no-go calls are inspectable business-decision history (NON-GxP decision support), not spreadsheet rows that drift.
• Anchors the Commercial bundle and, per the ADR-PLT-008 dual-bundle membership, the design-and-decision bundle with Control + Calculate — distinct from Corridor, the separate Market-Access / HEOR app (ADR-PLT-132).
• Grounded-AI decision Q&A answers strategy questions in plain language — cited to the org's own program-economics record and consumed Calculate eNPV/VoI artifacts, cite-or-refuse, routed through the audited Clarion gateway (never a direct provider call); commercial-data-partner ingestion extends the assumption surface further.